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Infertility is a disease that affects 1 out of 6 reproductive-age couples.  The causes are diverse 30 
including, but not limited to, polycystic ovaries (PCO), male factor (MF), and when all sources 31 
have been ruled out, the couple is defined as having unexplained infertility.  While each etiology 32 
is distinct, they are all typically associated with lower implantation potential and poorer 33 
pregnancy outcomes.  The aim of this study was to characterize the global transcriptome of 34 
human blastocysts, from patients presenting with specific infertility etiologies, to elucidate novel 35 
biological pathways that may influence downstream implantation.  Surplus, cryopreserved, day 36 
5 blastocysts of transferrable quality were donated with Institutional Review Board (IRB) 37 
approval and patient consent for transcriptome microarray analysis.  The human blastocyst 38 
transcriptome contained 13,136 annotated genes with the most significant alteration observed 39 
for blastocysts derived from infertile PCO patients.  869 genes were differentially expressed in 40 
PCO blastocysts, 348 in MF blastocysts, and 473 in blastocysts from unexplained etiology 41 
compared to fertile, donor controls (P<0.05; >2-fold).  Validation utilizing real-time quantitative 42 
PCR was performed on genes belonging to enriched pathways including:  BCL2L10, HSPA1A, 43 
HSPA1B, ATF3, FGF9, LEFTY1, LEFTY2, GDF15, INHBA, AJAP1, CDH9, and LAMA4 44 
(P<0.05; >2-fold).  Functional annotation of biological and molecular processes revealed both 45 
similarities, as well as differences, across the infertility groups.  All etiologies displayed 46 
transcriptome alterations in signal transducer activity, receptor binding, reproduction, cell 47 
adhesion, and response to stimulus.  However, blastocysts from PCO patients were also 48 
enriched for apoptosis while MF blastocysts displayed enrichment for cancer processes.  49 
Blastocysts from couples with unexplained infertility were enriched for pathways related to 50 
various disease states which included mTOR and adipocytokine signaling.  In conclusion, 51 
underlying patient infertility diagnosis is reflected in the blastocyst transcriptome, which may 52 
then impact developmental competence and implantation outcomes.  Ongoing research could 53
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result in the development of new laboratory or clinical therapies, improving patient diagnosis 54 
and management. 55 
 56 


























The World Health Organization (WHO) estimates that 1 out of 6 couples struggle with 81 
infertility and the origins are equally distributed between male and female.  There are many 82 
different causes of infertility including, among others, polycystic ovaries (PCO) and male factor 83 
(MF).  Infertility can be the result of a variety of problems ranging from genetic to hormonal and 84 
even environmental.  When all known sources have been ruled out, the couple is defined as 85 
idiopathic or unexplained.   86 
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women 87 
of reproductive age and a major cause of female factor infertility (Sirmans and Pate, 2013).  It is 88 
the result of hormonal imbalances, typically excess androgen production, which lead to rare or 89 
irregular ovulation (Krishnan and Muthusami, 2017).  Unlike PCOS, women diagnosed with 90 
polycystic ovaries (PCO) do not have a metabolic condition but have ovaries with abnormally 91 
high follicle counts and can still possess hormonal imbalances.  PCO is far more common than 92 
PCOS, affecting anywhere from 20-30% of the population and the causes are largely unknown 93 
(Koivunen et al. , 1999).  PCO patients are often infertile due to anovulation, thereby requiring 94 
assisted reproductive technologies (ART) to conceive.  High miscarriage rates are associated 95 
with this infertility phenotype, as well as decreased fertilization after IVF, suggesting poorer 96 
quality oocytes and embryos (Hardy et al. , 1995). 97 
Male factor infertility, which is almost always defined as abnormal semen analysis based 98 
on WHO guidelines, is solely responsible for 20-30% of human infertility and is a contributing 99 
factor in half of all couples presenting for ART (Agarwal et al. , 2015).  Problems with sperm 100 
production can originate from many different factors including hormonal, environmental, and 101 
even on a physical level within the testicle, causing problems with the seminiferous tubules.  102 
These tubules contain the Sertoli cells that act as nourishment for developing germ cells and 103 
are the location for spermatogenesis.  Poor semen parameters have been shown to result in 104 
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delayed and failed fertilization, as well as compromised embryo development and quality (Janny 105 
and Menezo, 1994, Ron-el et al. , 1991). 106 
Unexplained infertility is diagnosed in about 15-30% of infertile couples and is difficult to 107 
treat due to the unknown underlying etiology (Practice Committee of the American Society for 108 
Reproductive, 2006).  It is defined as the inability to conceive after 12 months of regular, 109 
unprotected intercourse and when all recommended fertility assessments fail to reveal any 110 
anomaly (Quaas and Dokras, 2008).  Patients can present with varying infertility histories 111 
including multiple IVF failures, poor embryo development, as well as lengthy periods of infertility.  112 
A retrospective review of 45 studies found that couples with this diagnosis have, on average, a 113 
1-4% chance of achieving pregnancy during any given menstrual cycle without utilizing ART 114 
(Guzick et al. , 1998).  Nevertheless, 40-60% will spontaneously conceive within 3 years 115 
GHSHQGLQJRQWKHIHPDOHSDUWQHU¶VDJHand this rate can increase to as high as 75% with the 116 
use of ART (Daniela Galliano, 2015).  ART techniques can also potentially help further address 117 
the cause of infertility in these patients (i.e. low fertilization rates, embryo fragmentation, 118 
abnormal oocytes, etc.) as well as improve time to conception. 119 
A fertilized oocyte must not only facilitate the syngamy of the male and female genomic 120 
contributions but also undergo a series of cellular divisions before embryonic genome activation 121 
is initiated (Fragouli et al. , 2013).  Both the timing of the activation, as well as the synchrony of 122 
genes activated, must be accurately controlled to produce a blastocyst stage embryo that is 123 
viable and developmentally competent for implantation to occur (Latham and Schultz, 2001).  In 124 
the mouse model, studies have observed two waves of embryonic gene transcription, the first 125 
corresponding to zygotic genome activation which occurs at the 1-2 cell stage, and the second 126 
occurring during the morula-to-blastocyst transition (Hamatani et al. , 2004a).  While these 127 
transcriptional events are similar in the human embryo, the timing is different with the zygotic 128 
genome activation occurring at the 4-8 cell stage (Niakan et al. , 2012).  Any irregularities during 129 
this critical time can lead to embryos that are incompetent and unable to implant.   130 
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The interactions between the blastocyst and the uterus that result in successful 131 
implantation are directed by an equally complex molecular dialogue (Fitzgerald et al. , 2008).  132 
Uterine receptivity has been extensively studied on all molecular levels, including the cross-talk 133 
between the embryo and endometrium which is quite extensive and results in an environment 134 
ideal for embryo adhesion and placentation (Miravet-Valenciano et al. , 2015).  It has also been 135 
shown that viable mouse embryos have a specific gene expression profile that favors uterine 136 
attachment and invasion of the maternal endometrium.  Chaen et al. found that ovarian 137 
estrogen indirectly coordinates mouse blastocyst adhesion through integrin activation in the 138 
blastocyst (Chaen et al. , 2012).  Additionally, a mammalian model for blastocyst activity has 139 
shown that specific molecular signaling directs either blastocyst activation or dormancy, 140 
affecting implantation competency (Hamatani et al. , 2004b).  Our lab has previously reported 141 
that differential mouse trophectoderm gene expression following embryo biopsy is associated 142 
with murine blastocyst implantation success.  Specifically, higher gene expression of B3gnt5, 143 
Cdx2, Eomes, and Wnt3a were predictive of sustained implantation.  In contrast, decreased 144 
gene expression of Eomes and Wnt3a were associated with absorption or pregnancy loss and 145 
decreased gene expression of B3gnt4 and Cdx2 were observed with negative outcomes (Parks 146 
et al. , 2011).  147 
There is limited knowledge of the human preimplantation embryo transcriptome and how 148 
it correlates to pregnancy outcomes. Jones et al. examined the transcriptome of human 149 
trophectoderm biopsies and identified more than 7000 transcripts expressed exclusively in 150 
viable blastocysts (Jones et al. , 2008).  A more recent study performed single-cell RNA 151 
sequencing on both human and mouse preimplantation embryos to determine a dataset of 152 
genes that are important for pluripotency (Blakeley et al. , 2015).  Ongoing transcriptome 153 
analysis in our lab revealed differential gene expression from blastocysts obtained from PCO 154 
women compared with donor controls. Over 800 genes were found to be disrupted in these 155 
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PCO blastocysts in addition to 12 altered protein biomarkers, demonstrating a link between 156 
patient infertility phenotype and embryo development (Katz-Jaffe et al. , 2010).   157 
The objective of the present study was to further explore the global transcriptome of 158 
human blastocysts from patients with differing infertility etiologies, specifically PCO, male factor, 159 
and unexplained infertility, to uncover novel biological pathways associated with their infertility 160 
that may influence downstream implantation outcomes.  These findings will further our 161 
understanding of the impact of infertility diagnoses on the embryonic molecular signature at the 162 
time of implantation, and may lead to refined lab-based and clinical approaches for improving 163 
IVF outcomes. 164 
 165 
Materials and Methods 166 
Human blastocysts 167 
Surplus, cryopreserved, anonymous, human blastocysts from IVF patients with specific 168 
infertility diagnoses were donated with Institutional Review Board (IRB) consent. All embryos 169 
were considered to be transferable quality with a grade of 3BB or better on day 5 of embryo 170 
development (Gardner and Schoolcraft, 1999). Either slow freezing or vitrification protocols 171 
were used to cryopreserve the blastocysts (Kuwayama, 2007, Veeck et al. , 2004) which were 172 
grouped according to a single distinct infertility diagnosis: n=50 young donor oocyte controls 173 
with no male factor infertility; n=50 polycystic ovaries (PCO); n=50 male factor infertility (MF); 174 
and n=50 unexplained infertility (UE). Every blastocyst used in this study came from a different 175 
patient (female <38 years old, male <40 years old) and all patients had successful pregnancies 176 
from the same IVF cohort as the blastocyst used for research.  Patients diagnosed with PCO 177 
had polycystic ovaries confirmed by ultrasound but did not have any endocrine or metabolic 178 
abnormalities, as determined by androgen levels, fasting glucose and insulin levels, and oral 179 
glucose tolerance testing. MF infertility patients were all diagnosed based on WHO guidelines 180 
as oligoasthenoteratozoospermia with sperm concentration <15 million/ml, motility <32%, and 181 
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<4% normal morphology.  UE infertility was defined following a negative fertility workup which 182 
included normal semen analysis, normal ovarian reserve testing, and normal uterine 183 
assessment with no prior failures or missed abortions. 184 
Blastocyst thaw and RNA isolation 185 
Blastocysts were either thawed or warmed using routine laboratory procedures, with an 186 
overall 95% survival rate. Blastocysts in each distinct infertility diagnosis group were pooled 187 
(n=25 per pool, 2 pools per group) and RNA was isolated using the PicoPure RNA Isolation Kit 188 
(ThermoFisher Scientific, Grand Island NY) SHUWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV with minor 189 
modifications.  Briefly, blastocysts were lysed in 10ul of Extraction Buffer before adding 1 190 
volume of 70% ethanol and binding to a silica-based membrane.  Samples were then washed 191 
and on-column deoxyribonuclease treated (Qiagen, Valencia CA) prior to elution in 20ul and 192 
storage at -80°C. 193 
Microarray hybridization 194 
Isolated RNA from each group was reverse transcribed, amplified, and labeled using the 195 
LowInput QuickAmp Labeling Kit (Agilent Technologies, Santa Clara CA). Quantification and 196 
quality of total RNA was performed using the High Sensitivity RNA ScreenTape on a 4200 197 
TapeStation System (Agilent Technologies).  Quantification and specific activity of labeled 198 
cRNA was determined using the NanoDrop® ND-1000 spectrophotometer (ThermoFisher 199 
Scientific).  600ng of cRNA was then applied to the SurePrint G3 Human Gene Expression 200 
Microarray containing 50,599 biological features (Agilent Technologies) SHUWKHPDQXIDFWXUHU¶V201 
instructions and hybridized in a rotating oven for 17 hours at 65°C.  Arrays were washed and 202 
then scanned using a DNA Microarray Scanner C (Agilent Technologies).  Feature Extraction 203 
software was utilized to extract gene expression data (Agilent Technologies). 204 
Real-time quantitative PCR Validation 205 
RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit 206 
(ThermoFisher Scientific).  cDNA was diluted 1:5 in nuclease-free water and Real-time 207 
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quantitative PCR (RT-qPCR) was performed for validation of specific differentially expressed 208 
genes identified from the transcriptome analysis.  Absolute expression was quantified relative to 209 
a standard curve using slope and PCR efficiencies and normalized to a stable housekeeping 210 
gene, GAPDH.  Briefly, Power SYBR® Green PCR Master Mix (ThermoFisher Scientific) was 211 
combined with 5uM primer mix and 5ul diluted cDNA for a total volume of 25ul.  The reaction 212 
was incubated at 95°C for 10 minutes, followed by 40 cycles of amplification at 95°C f or 15 213 
seconds and 60°C for 1 minute with a final dissociation stage for melt curve analysis. 214 
Statistical analysis 215 
Transcript analysis was performed using GeneSpring software (version 7, Agilent 216 
Technologies), including principal component analysis (PCA), unsupervised hierarchical 217 
clustering, one way ANOVA and unpaired t-test with Benjamini-Hochberg correction 218 
(significance at P<0.05).  qPCR analysis was performed with REST 2009 software (Qiagen) 219 
which uses the correction for exact PCR efficiencies with mean crossing point deviations 220 
between sample and control groups to determine an expression ratio that is tested for 221 
significance by a Pair Wise Fixed Reallocation Randomization Test.  Significance was defined 222 
as P<0.05. 223 
Ethical approval 224 
 All human participants were consented and this study was approved by an institutional 225 
review board. 226 
 227 
Results 228 
The blastocyst transcriptome according to infertility diagnosis 229 
The overall human blastocyst transcriptome contained 33,587 gene transcripts which 230 
included numerous splicing variants and isoforms, revealing 13,136 annotated genes.  PCA and 231 
unsupervised hierarchical clustering distinguished each of the four blastocyst groups by their 232 
transcriptomes (Figure I). The most significant transcriptome variation was observed in 233 
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blastocysts derived from infertile PCO patients. Compared to donor controls, significant 234 
differences in transcription (>2 fold; P<0.05) were observed for 869 genes in PCO blastocysts, 235 
348 genes in MF blastocysts, and 473 genes in blastocysts from couples with unexplained 236 
infertility (Figure II).  Both upregulation and downregulation were observed in each group:  PCO 237 
= 647 increased, 222 decreased; MF = 143 increased, 205 decreased; UE = 305 increased, 168 238 
decreased (Table I). 239 
Functional annotation of PCO blastocysts was performed using DAVID 240 
(https://david.ncifcrf.gov) which revealed significant differences in gene ontology including:  cell 241 
communication, differentiation and adhesion, reproduction, transcription factor activity, 242 
regulation of apoptosis, receptor binding, signal transducer activity, and response to hormone 243 
stimulus.  Pathway analysis identified enriched biological processes with altered transcripts in 244 
PCO vs. control blastocysts (P<0.05) including gap junction proteins and genes involved in p53 245 
signaling, calcium signaling, TGF-beta signaling, histidine metabolism, and apoptosis (Table I).   246 
Transcriptome analysis of MF blastocysts resulted in some similar gene ontology 247 
differences in relation to PCO blastocysts that included:  signal transduction, regulation of 248 
apoptosis, cell adhesion, reproduction and receptor binding.  Unique differences were also 249 
observed for MF including:  response to stress, regulation of growth, and protein dimerization 250 
activity.  Pathway analysis of MF vs. control blastocysts revealed enrichment in TGF-beta, ErbB, 251 
B cell receptor and GnRH signaling (Table I).   252 
Functional annotation of UE blastocysts also had similar outcomes to PCO blastocysts in 253 
signal transducer activity, receptor binding, cell differentiation, adhesion and morphogenesis, 254 
reproduction, and response to stimulus, among others.  Unique differences for UE included:  255 
oxidoreductase activity, protein dimerization activity, and monooxygenase activity.  Pathway 256 
analysis of UE vs. control blastocysts had some similarities (TGF-beta signaling and focal 257 
adhesion) compared to the other two groups but many more differences including affected 258 
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pathways:  Type I diabetes, antigen processing, leukocyte migration, autoimmune thyroid 259 
disease, systemic lupus erythematosus , mTOR signaling, and adipocytokine signaling (Table I). 260 
Microarray Validation 261 
RT- qPCR was used to validate the microarray data by investigating the expression 262 
levels of genes involved in stress response, apoptosis, cell growth and adhesion, and 263 
embryonic development.  qPCR results confirmed a significantly higher expression of the stress 264 
sensing protein activating transcription factor 3 (ATF3) in PCO blastocysts compared to donor 265 
controls (P<0.05) and  lower levels of anti-apoptotic oocyte-inherited gene (BCL2L10) (P<0.05) 266 
and the heat shock proteins HSPA1A and HSPA1B (P<0.05; Figure III).  Blastocysts from 267 
patients with MF infertility displayed an increased expression of growth differentiating factor 15 268 
(GDF15) (P<0.05) and the cell proliferation regulator, INHBA (P<0.05; Figure IV) as observed in 269 
the microarray data.  Additionally, reduced expression was validated in MF blastocysts for 270 
fibroblast growth factor 9 (FGF9) (P<0.05), and left-right determination factors 1 and 2 (LEFTY1, 271 
LEFTY2) (P<0.05; Figure IV).  Three genes were also confirmed to have reduced expression in 272 
blastocysts with UE infertility as observed in the microarray data:  Adherens Junctions 273 
Associated Protein 1 (AJAP1), cadherin 9 (CDH9), and Laminin Subunit Alpha 4 (LAMA4) (All 274 
P<0.05; Figure V). 275 
 276 
Discussion 277 
This study highlighted that the human blastocyst transcriptome is significantly impacted 278 
by the type of patient infertility diagnosis (PCO, MF, and UE).  All three of the infertility 279 
diagnoses shared transcriptome alterations, with PCO blastocysts displaying the greatest 280 
transcriptome variation.  An altered blastocyst transcriptome has the potential to impact overall 281 




The expression of genes involved in stress response and apoptosis were significantly 284 
different in PCO blastocysts compared to donor controls, suggesting a PCO environment has a 285 
VLJQLILFDQWLPSDFWRQWKHGHYHORSLQJEODVWRF\VW¶VWUDQVFULSWRPHLQFOXGLQJDOWHUDWLRQVLQstress 286 
signaling pathways and the regulation of apoptosis.  These findings are consistent with those of  287 
Wang et al, who reported differential expression of 650 transcripts in the ovaries of women with 288 
PCOS compared to normal ovaries and found similar alterations in pathways involved in stress 289 
response, apoptosis, and regulation of transcription (Wang et al. , 2014).  A higher expression of 290 
ATF3 and lower expression of BCL2L10, HSPA1A and HSPA1B in PCO blastocysts was 291 
observed in this study compared with donor controls.  ATF3, a stress sensor, increases p53 292 
protein levels and transcription of p53-responsive genes that result in either cell arrest and DNA 293 
repair or apoptosis (Yan et al. , 2005), thereby maintaining DNA integrity.  In the developing 294 
embryo, highly regulated apoptotic events are critical for embryo homeostasis and survival.  The 295 
BCL2 proteins are both anti- and pro-apoptotic; BCL2L10 is an anti-apoptotic oocyte-inherited 296 
transcript and elimination of BCL2L10 accelerates oocyte death (Guillemin et al. , 2009).  297 
HSPA1A and B are involved in embryonic genome activation and decreased expression has 298 
been observed in mammalian arrested embryos (Le Masson and Christians, 2011, Pan et al. , 299 
2014).  Likewise, gene expression analyses of oocytes from PCOS women also revealed 300 
reduced expression in these heat shock proteins (Wood et al. , 2007).  Decreased fertilization 301 
rates after IVF, as well as a higher risk of miscarriage are associated with the PCO infertility 302 
diagnosis.  Altered expression levels of each of these genes in PCO may disrupt the normal 303 
balance of apoptosis in the pre-implantation embryo, with downstream consequences for 304 
implantation and developmental outcomes. 305 
Blastocysts derived from MF infertility were significantly altered for TGF-beta and ErbB 306 
signaling pathways which are crucial during cell growth and proliferation.  GDF15 is a gene 307 
belonging to the TGF-beta superfamily and plays a role in regulating inflammatory and apoptotic 308 
pathways.  The increased expression observed for GDF15 in MF blastocysts is associated with 309 
13 
 
numerous disease states including inflammation and oxidative stress.  Likewise, INHBA, which 310 
encodes the same TGF-beta superfamily of proteins, was also found to have increased 311 
expression in MF blastocysts.  It is a negative regulator of gonadal stromal cell proliferation, 312 
thus excess expression would lead to inappropriate decreases in cell proliferation which could 313 
negatively impact implantation potential.  Decreased gene expression in MF blastocysts was 314 
observed for FGF9, LEFTY1, and LEFTY2.  FGF9 is involved in many biological processes 315 
including embryo development, cell growth, and morphogenesis.  It has been found to be 316 
required for stimulating Erk1/2 activation in differentiating spermatagonia (Tassinari et al. , 317 
2015).  LEFTY proteins are critical in sustaining pluripotency and implicated in differentiation of 318 
embryonic stem cells (Khalkhali-Ellis et al. , 2016).  Inactive LEFTY has been shown to result in 319 
embryos that become entirely mesoderm and fail to develop (Hamada et al. , 2002).  Poor 320 
sperm parameters in MF patients are correlated with fertilization failure and compromised 321 
embryo quality and development.  Decreases in the expression of these genes could severely 322 
impact embryo developmental competence, which is crucial for implantation. 323 
Important pathways including cell differentiation and morphogenesis, reproduction, and 324 
response to stress were affected from blastocysts derived from patients with UE infertility.  325 
These pathways affect embryo growth and development as well as cell adhesion and migration.  326 
Decreased expression was observed for three genes involved in cell adhesion and migration:  327 
AJAP1, CDH9, and LAMA4.  AJAP1 has been observed to be decreased in various cancers and 328 
LQWHUDFWVZLWKȕ-catenin complexes that impact cell cycle function and apoptosis (Zeng et al. , 329 
2014).  The decreased expression observed in UE blastocysts could have a negative impact on 330 
the balance of apoptosis, possibly leading to inappropriate expression of genes that affect 331 
cellular invasion.  CDH9 belongs to a family of cell adhesion molecules that regulate 332 
morphogenesis and are involved in intracellular signaling pathways (Halbleib and Nelson, 333 
2006).  These cadherins are responsible for cell-cell adhesion during morula compaction, in 334 
addition to playing a role in tissue and organ development (Peyrieras et al. , 1983).  Decreased 335 
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expression would inhibit the ability of both early embryo development, as well as later fetal 336 
development in utero.  LAMA4 is a laminin that mediates the attachment, migration, and 337 
organization of cells into organized tissues during embryonic development.  Laminins are vital 338 
for organogenesis and have critical functions in several tissues including skin, muscle, and 339 
vasculature (Durbeej, 2010).  As the etiology of UE infertility is more ambiguous, many adverse 340 
outcomes are possible including poor embryo development and IVF failure.  The decreased 341 
expressed observed in UE blastocysts could have significant consequences to embryo 342 
implantation and ongoing development. 343 
The similarities between all infertility groups included transcriptome alterations in signal 344 
tranducer activity, receptor binding, reproduction, cell adhesion, and response to stimulus.  345 
These biological and molecular processes are all inter-related and crucial to embryo 346 
development and implantation which are processes characterized by cells that proliferate, 347 
migrate, and attach.  Receptors are generally transmembrane protein molecules that bind to 348 
signaling molecules in response to external stimuli.   Once a receptor protein receives a signal, 349 
a series of biochemical reactions is initiated which conveys those signals across a cell, 350 
triggering changes in cell function or state, known as signal transduction.  An example of this is 351 
Hedgehog (Hh) proteins which are expressed during vertebrate development.  Hh signaling has 352 
been observed during embryonic development and has significance during the growth of 353 
reproductive tissues including the gonad and uterus (Walterhouse et al. , 2003).  Cellular 354 
adhesion, in which cells interact to attach to a surface, regulates signal transduction and is an 355 
essential process for embryo implantation into the uterus lining.  It is therefore not surprising 356 
that all three infertility diagnoses shared blastocysts with transcriptome alterations in these 357 
important biological and molecular processes. 358 
The differences between each infertility group were more remarkable when studying 359 
their pathway analyses.  Blastocysts from women with PCO were enriched for apoptosis.  This 360 
is in concordance with data published showing that ovaries from women with PCO have 361 
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abnormal apoptotic activity and folliculogenesis (Cai et al. , 2013).  On the other hand, signaling 362 
pathways from blastocysts with MF infertility were largely involved in cancer processes.  Lian et 363 
al. also found that infertile men with maturation arrest had hyperactive germ cell proliferation as 364 
a result of the inhibition of tumor suppressor IRF1 by its microRNA, miR-383 (Lian et al. , 2010).  365 
Interestingly, UE infertility was enriched for pathways involved in mTOR and adipocytokine 366 
signaling, both of which are related to various disease states.  This could explain some of the 367 
difficulties in treating patients with unknown infertility as the cause of their reproductive 368 
deficiencies could be the result of anything ranging from environmental to unknown disease risk 369 
factors.  For example, autoimmune disorders, such as lupus, have been shown to cause a 370 
ZRPDQ¶VLPPXQHV\VWHPWRUHMHFWDQHPEU\RWKHUHE\SUHYHQWLQJLPSODQWDWLRQLQWRWKHuterus 371 
(Mojarrad et al. , 2013). 372 
 373 
Conclusions 374 
This novel study suggests that underlying patient infertility diagnosis has an impact on 375 
the blastocyst transcriptome, modifying genes that may affect developmental competence and 376 
implantation outcomes. Ongoing research determining how transcription alterations are linked to 377 
inferior pregnancy outcomes for PCO, MF, and UE patients is crucial to improving IVF success.  378 
This is especially true for UE patients as a more defined infertility diagnosis could translate into 379 
more targeted clinical management.  Understanding how different infertility etiologies contribute 380 
to embryo viability may also lead to the development of new laboratory and clinical therapies.  381 
An example of this type of clinical advancement is the endometrial receptivity array which 382 
identifies endometrial receptivity for patients with repeated implantation failure (Ruiz-Alonso et 383 
al. , 2013).  Further studies could lead to similar advancements including individualized embryo 384 
culture systems and custom stimulation and frozen embryo transfer protocols, thereby 385 
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Table I.  Significantly altered transcripts and pathways associated with specific infertility 515 





# ನGenes   
 (P<0.05; >2-fold) 
# ಪ Genes    
  (P<0.05; >2-fold) 
Enriched Pathways                                              
(P<0.05; >2-fold) 
PCO 647 222 p53 signaling, TGF-beta signaling, apoptosis, histidine 
metabolism 
MF 143 205 TGF-beta signaling, ErbB signaling, GnRH signaling, B cell 
receptor signaling 
UE 305 168 
mTOR signaling, autoimmune thyroid disease, systemic 
lupus erythematosus, Type I diabetes, and adipocytokine 
signaling 
Figure 1.  Differential transcriptome profiles based on infertility 
diagnosis. Human blastocyst transcriptomes from unexplained infertility 
(UE) (lanes 1 and 2), polycystic ovaries (PCO) (lanes 3 and 4), 
male factor (MF) (lanes 5 and 6) and control (lanes 7 and 8). 
Unsupervised hierarchical clustering clearly separated the transcriptomes 
of the four groups, with the most significant variation in gene 
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Figure 2. Venn diagram depicting gene overlap of differentially 
expressed transcripts between the infertility diagnoses groups. P < 0.05; 
>2-fold; one-way ANOVA and unpaired t-test with Benjamini± 













Figure 3. Altered expression of genes involved in apoptosis and 
stress response in PCO blastocysts. Quantitative PCR (qPCR) was 
performed to validate expression levels of activating transcription factor 
3 (ATF3), BCL2 like 10 (BCL2L10) and heat shock protein family A 
members 1A and 1B (HSPA1A and HSPA1B) in donor control and 
PCO blastocysts with peptidylprolyl isomerase A (PPIA) transcription 
as the constant internal reference gene. A significant increase in ATF3 
expression was observed, while BCL2L10, HSPA1A and HSPA1B displayed 
significantly lower expression in PCO blastocysts, compared 








































Figure 4. Altered expression of genes involved in cell growth and 
differentiation in MF blastocysts. qPCR was performed to validate 
expression levels of growth differentiation factor 15 (GDF15), inhibin 
beta A subunit (INHBA), fibroblast growth factor 9 (FGF9) and leftright 
determination factors 1 and 2 (LEFTY1 and LEFTY2) in donor 
control and MF blastocysts with GAPDH transcription as the constant 
internal reference gene. (A) Expression of FGF9, LEFTY1 and LEFTY2 
was significantly lower and (B) GDF15 and INHBA significantly higher 
in MF blastocysts compared to donor controls; *P < 0.05; pair-wise 













































































Figure 5. Altered expression of genes involved in cell adhesion and 
migration in UE blastocysts. qPCR was performed to validate expression 
levels of adherens junctions associated protein 1 (AJAP1), cadherin 
9 (CDH9) and laminin subunit alpha 4 (LAMA4) in donor control 
and UE blastocysts with GAPDH transcription as the constant internal 
reference gene. All three genes were significantly decreased in expression 
in UE blastocysts compared to donor controls; *P < 0.05; pairwise 













































PCO, polycystic ovaries; MF, male factor infertility; UE, unexplained infertility; TGF, transforming 
growth factor; ErbB, epidermal growth factor; mTOR, mechanistic target of rapamycin. 
 
Statistical method: one-way ANOVA and unpaired t-test with Benjamini±Hochberg correction. 
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(P<0.05; >2-fold) 
PCO 647 222 p53 signaling, TGF-beta signaling, apoptosis, histidine 
metabolism 
MF 143 205 TGF-beta signaling, ErbB signaling, GnRH signaling, B cell 
receptor signaling 
UE 305 168 
mTOR signaling, autoimmune thyroid disease, systemic 
lupus erythematosus, Type I diabetes, and adipocytokine 
signaling 
